Home › Spinal Cord Injuries › NCT07136688
Tibial Nerve Stimulation for Pediatric Spina Bifida Neurogenic Bladder
A Randomized Control Trial of Transcutaneous Tibial Nerve Stimulation for Neurogenic Bladder in the Pediatric Population
Who can join
Ages 4 to 17 · All sexes
Full eligibility criteria
Inclusion Criteria: * chronic neurogenic bladder * Spina Bifida diagnosis * Use of overactive bladder medication(s) * Stable bladder medications for ≥ 3 months Exclusion Criteria: * Progressive SCI (ex: transverse myelitis, polio, etc.) * Other lower urinary tract pathology or surgery * 2+ pitting edema in the legs that does not resolve * Known peripheral neuropathy or injury to the path of the tibial nerve * Cancer in the tibial nerve pathway and/or lower urinary tract * Inability to elicit the motor response with electric stimulation * Inability to complete the tTNS proficiency checklist (guardians) * Non-English speaking (guardians)
About the study
The purpose of this study is to determine the safety, feasibility, and compliance of a daily home transcutaneous tibial nerve stimulation (tTNS) protocol in children with chronic neurogenic bladder (NB) provided by self or caregiver for 4 weeks and to estimate the efficacy of tTNS
What is being tested
- Stamobil electric stimulator (device)
- sham tTNS device (device)
Sponsor: The University of Texas Health Science Center, Houston · Participants: 20 · Started: Mar 27, 2026
Contact the study team
- Argyrios Stampas, MD, MS · Phone: (713) 797-5007
- Nancy Rosa · Phone: 713-797-5765
Official record on ClinicalTrials.gov — NCT07136688
Locations in the U.S.
| Texas | The University of Texas Health Science Center and Houston, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.